Trials / Not Yet Recruiting
Not Yet RecruitingNCT06119997
Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
Liver fibrosis screening is possible at the asymptomatic stage through a healthcare management strategy currently recommended for patients with risk factors for chronic liver disease. It is based on a sequential strategy involving a 1st-line test, fibrosis score calculation (FIB-4). Given this opportunity to identify advanced fibrosis in asymptomatic patients, the project aims to set up this screening program in the Grenoble area with Biogroup Laboratories, in collaboration with the Hepato-gastroenterology department (HGE) of Grenoble University Hospital. The aim of this study is to evaluate the success of sequential screening using FIB-4, followed by a specialized fibrosis test for the diagnosis of advanced hepatic fibrosis
Conditions
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2027-04-30
- Completion
- 2027-07-30
- First posted
- 2023-11-07
- Last updated
- 2025-04-20
Source: ClinicalTrials.gov record NCT06119997. Inclusion in this directory is not an endorsement.